NeuBase Therapeutics, Inc. (NBSE) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 12.83M |
| Enterprise Value | -4.32M |
| P/E Ratio | -0.02 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.03 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.48 |
| Fiscal Year | September 30, 2022 |
| Most Recent Quarter | September 30, 2023 |
| Profit Margin | 0 |
| Operating Margin | 0 |
| Return On Assets | -1.05 |
| Return On Equity | -0.89 |
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | -1.26M |
| EBITDA | -32.92M |
| Net Income | -34.23M |
| Diluted EPS | -21.08 |
| Total Cash | 12.57M |
| Total Cash/Share | 14.25 |
| Total Debt | 5.34M |
| Total Debt/Equity | 0.26 |
| Current Ratio | 5.92 |
| Book Value Per Share | 14.28 |
| 52-Week Change | -89.84 |
| 52-Week High | 4.44 |
| 52-Week Low | 0.36 |
| Moving Average 50 Days | 0.47 |
| Moving Average 200 Days | 0.72 |
| Average Volume | 128,236 |
| Shares Outstanding | 3.75M |
| % Held by Institutions | 0.58 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:20 |
| Last Split Date | June 15, 2023 |